Davis Polk and Maples and Calder advised CARsgen Therapeutics Holdings Limited, while Herbert Smith Freehills and Zhong Lun advised Goldman Sachs and UBS on the deal....
CARsgen Therapeutics Holdings Limited’s Listing on the Stock Exchange of Hong Kong
Zai Lab’s $857.5 Million Shares Offering
Davis Polk advised Zai Lab Limited in the deal, while Simpson Thacher represented the underwriters. Zai Lab Limited executed its offering of 5,492,400 American depositary shares,...
I-Mab’s $177 Million ADSs Follow-on Secondary Offering
Davis Polk advised the representatives of the underwriters on the offering. Certain selling shareholders of I-Mab issued $177 million SEC-registered follow-on secondary offering of 3,283,950 American depositary...
InnoCare Pharma Limited’s $287 Million Initial Public Offering
Davis Polk and Ogier advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed its initial public offering and listing on the Hong Kong Stock...